The efficacy and safety of irbesartan in primary hypertension even if a dose is missed: Results from the NO PROBLEM Study

By Kabakci Giray   Kaya Baris Ergun   Tulumen Erol   Kocabas Ugur   Abali Gulcan   Deveci Onur   Aytemir Kudret   Tokgozoglu Lale   Ozkutlu Hilmi  

Blood Pressure, Vol. 19, Iss. 1, 2010-02 ,pp. : 5-9

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension

By Mallion Jean-Michel   Omboni Stefano   Barton John   Van Mieghem Walter   Narkiewicz Krzysztof   Panzer Peter-Klaus   Puig Juan Garcíía   Stefanadis Christodoulos   Zweiker Robert    

Blood Pressure, Vol. 20, Iss. 1, 2011-04 ,pp. : 3-11

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of nifedipine GITS in Chinese patients with hypertension - A post-marketing surveillance study

By Huo Yong   Zhang Jian   He Qing   Chen Hong   Ma Jishun   Landen Harald  

Blood Pressure, Vol. 16, Iss. 1, 2007-03 ,pp. : 18-23

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of early versus late titration of fixed-dose Irbesartan/hydrochlorothiazide: ACTUAL study

By  

Blood Pressure, Vol. 21, Iss. 1, 2012-02 ,pp. : 69-69

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension

By Verdecchia Paolo   Calvo Carlos   Möckel Volker   Keeling Lucy   Satlin Andrew  

Blood Pressure, Vol. 16, Iss. 6, 2007-01 ,pp. : 381-391

Informa Healthcare

Access to resources Recommend Favorite